National Seating & Mobility announces planned Eve exoskeleton distribution partnership
National Seating and Mobility →On June 25, 2026, National Seating & Mobility and Wandercraft announced a commercial partnership to prepare for access to Eve, Wandercraft's personal exoskeleton designed for home use. Under the agreement, NSM would become the exclusive complex rehabilitation technology distribution partner following FDA clearance. At the time of the announcement, Eve remained under regulatory review. NSM planned to use its service network to support evaluation, education, access and delivery for eligible clients. The companies also described joint work with clinicians, insurers and other stakeholders, and broader awareness of Wandercraft's rehabilitation technology. The announcement establishes a conditional distribution arrangement, not an equity investment or proof of regulatory approval.